EARNEST Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-179
Closed -$15.5K 414
2023
Q3
$15.5K Hold
179
﹤0.01% 543
2023
Q2
$16.9K Hold
179
﹤0.01% 522
2023
Q1
$13.5K Hold
179
﹤0.01% 556
2022
Q4
$13.8K Hold
179
﹤0.01% 550
2022
Q3
$12K Hold
179
﹤0.01% 548
2022
Q2
$9K Hold
179
﹤0.01% 619
2022
Q1
$10K Hold
179
﹤0.01% 639
2021
Q4
$9K Hold
179
﹤0.01% 691
2021
Q3
$9K Hold
179
﹤0.01% 670
2021
Q2
$10K Hold
179
﹤0.01% 649
2021
Q1
$11K Hold
179
﹤0.01% 600
2020
Q4
$10K Hold
179
﹤0.01% 604
2020
Q3
$8K Hold
179
﹤0.01% 614
2020
Q2
$9K Hold
179
﹤0.01% 583
2020
Q1
$9K Hold
179
﹤0.01% 526
2019
Q4
$9K Hold
179
﹤0.01% 607
2019
Q3
$8K Hold
179
﹤0.01% 615
2019
Q2
$8K Hold
179
﹤0.01% 623
2019
Q1
$9K Hold
179
﹤0.01% 591
2018
Q4
$8K Hold
179
﹤0.01% 582
2018
Q3
$10K Hold
179
﹤0.01% 574
2018
Q2
$9K Hold
179
﹤0.01% 594
2018
Q1
$11K Hold
179
﹤0.01% 534
2017
Q4
$11K Buy
+179
New +$11.1K ﹤0.01% 522
2017
Q1
Sell
-179
Closed -$13K 347
2016
Q4
$13K Buy
+179
New +$12.9K ﹤0.01% 466

Other funds holding CAH

EARNEST Partners's CAH Position: Q4 2023 in Review

EARNEST Partners sold out of Cardinal Health (CAH) in Q4 2023, closing a stake of 179 shares — an estimated $15.5K sold.

EARNEST Partners first reported a position in CAH in Q4 2016 and held it in 25 quarters. The position peaked at $16.9K in Q2 2023. 1,039 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

  • EARNEST Partners reported no remaining Cardinal Health position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 179 Cardinal Health shares in Q4 2023, an estimated $15.5K.
  • EARNEST Partners first reported a position in Cardinal Health in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Cardinal Health position peaked at $16.9K in Q2 2023.
  • 1,039 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.